Cite
MLA Citation
Y Zabana Abdo et al.. “DOP40 Comorbidities and epidemiological risk factor but not immunosuppressive therapies increase the risk of COVID-19 in Inflammatory Bowel Disease (IBD): An ENEIDA-based, case-control study.” Journal of Crohn's and colitis, vol. 15, n.d., pp. S078–S079. http://access.bl.uk/ark:/81055/vdc_100130765034.0x00001e